DavidWheeler University College LondonUnited Kingdom

DavidWheeler
David C WheelerrDavid is Professor of Kidney Medicine at University College London and Honorary Consultant Nephrologist at the Royal Free London NHS Foundation Trust. He is a clinical scientist interested in chronic kidney disease (CKD). He has participated in the development and delivery of several large-scale clinical trials testing lipid lowering regimens (SHARP), calcimimetics (EVOLVE), intravenous iron (PIVOTAL), SGLT2 inhibitors (CREDENCE and DAPA-CKD) and HIF stabilisers (ASCEND) in patients with CKD. He was co-chief investigator for the DAPA-CKD study (with Hiddo Lambers Heerspink). David has been involved in the development of Clinical Practice Guidelines for several organisations, most recently for Kidney Disease: Improving Global Outcomes (KDIGO). He served as KDIGO co-chair between 2012 and 2019. Other recent roles include Chair of the International Society of Nephrology Advancing Clinical Trials (ISN-ACTs) committee. In the UK, he is National Institute of Health Research (NIHR) Specialty Lead for Renal Disorders.
Upload Picture
https://storage.unitedwebnetwork.com/files/1099/4ebc6caaa51e79209f4061cd08dff279.jpg
First Name
David
Last Name
Wheeler
Institution
Country.
United Kingdom

Friday, February 7, 2025

Time Session
2:15 p.m.
3:45 p.m.
Bridging the Clinical Gap: Sustainable Strategies and Innovative Therapies for Global Kidney Health
Prof (Dr ) SanjeevGulati Chair sgulati2002@gmail.comIndia
  • Sustainable Community Approaches to Early CKD Detection
    RonaldGansevoort Speaker Dept. Nephrology, University Medical Center Groningen
  • Kidney Disease Treatment Gaps Worldwide - Where Are the Solutions?
    AdeeraLevin Speaker University of British Columbia and Providence Health CareCanada
  • The Promise of Emerging Therapies in Reducing the Global Kidney Disease Burden
    DavidWheeler Speaker University College LondonUnited Kingdom
  • Co-opting Patients as Partners in Kidney Care: How Do We Do It?
    ShilpanjaliJesudason Speaker Royal Adelaide Hospital and University of Adelaide, AustraliaAustralia
  • Co-opting Patients as Partners in Kidney Care: How Do We Do It?
    ShyamsundarMuthuramalingam Speaker Central Adelaide Local Health Network Australia
  • Q&A
Kesar Hall 202

Saturday, February 8, 2025

Time Session
2:15 p.m.
3:45 p.m.
What’s Next in Kidney Care Research? Innovations and Clinical Trials on the Horizon
AdeeraLevin Chair University of British Columbia and Providence Health CareCanada
AndreaViecelli Chair andrea.viecelli@health.qld.gov.auUniversity of QueenslandAustralia
Ajit singhNarula Chair narulaas@gmail.comIndia
  • Novel Trial Designs in Nephrology: Innovations and Structures
    MegJardine Speaker NHMRC Clinical Trials Centre, University of Sydney, AustraliaAustralia
  • What’s New in Clinical Trials?
    DavidWheeler Speaker University College LondonUnited Kingdom
  • Value of Different Outcomes in the Era of Precision Medicine
    RobertoPecoits Filho Speaker Arbor Research Collaborative for HealthUnited States
  • Conducting Trials in Low and Middle-income Countries
    SoumitaBagchi Speaker India
  • Innovations in Pediatric Nephrology Discovery and Clinical Trial Conduct
    ArpanaIyengar Speaker ST JOHN'S NATIONAL ACADEMY OF HEALTH SCIENCES, BANGALOREIndia
  • Q&A
Parijat Hall 201

Sunday, February 9, 2025

Time Session
9:45 a.m.
11:15 a.m.
HIT! High Impact Clinical Trials
DavidWheeler Chair University College LondonUnited Kingdom
  • What Have We Learned From CONVINCE?
    PeterBlankestijn Oral Abstract Presenter P.J.Blankestijn@umcutrecht.nlUniversity Medical Center UtrechtNetherlands
  • Design of the ZEUS Trial: Interleukin-6 Inhibition With Ziltivekimab for Cardiovascular Protection in Chronic Kidney Disease
    VladoPerkovic Oral Abstract Presenter vlado.perkovic@unsw.edu.auUniversity of New South Wales, Sydney, AustraliaAustralia
  • A Phase 1/2 Trial of Zigakibart in IgA Nephropathy (IgAN)
    JonathanBarratt Oral Abstract Presenter University of Leicester, Leicester, UKUnited Kingdom
  • Observational Cohort With Embedded Randomized Controlled Trials to Study Pregnancy-Associated Progression of Renal Disease: A Feasibility Study of Dietary Nitrate (Beetroot Juice) to Protect Kidney Function in Pregnant Women With Chronic Kidney Disease
    PriscillaSmith Oral Abstract Presenter priscilla.smith@kcl.ac.ukKings College Hospital LondonUnited Kingdom
  • Design of Randomized Embedded Adaptive Platform Clinical Trial in South Asian Kidney Biopsy-Proven Primary Glomerular Diseases: Multi-Center, Multi-Arm and Multi-Stage
    Selvin Sundar RajMani Oral Abstract Presenter selvinsr@gmail.comIndia
    SuceenaAlexander Oral Abstract Presenter Christian Medical College VelloreIndia
Auditorium Brahmkamal Hall